As of 2024-12-11, the Fair Value of Prometheus Biosciences Inc (RXDX) is -15.74 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 199.92 USD, the upside of Prometheus Biosciences Inc is -107.88%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 5Y Avg | |
| Net income | -29.72 | -37.14 | -90.19 | -141.75 | -74.70 | |
| YoY growth | -337.06% | -24.97% | -142.85% | -57.16% | -140.51% | |
| Market Cap (mil) | 9,558.81 |
| P/E | |
| Forward P/E |
| EPS | -3.15 |
| Avg earnings growth rate | -140.51% |
| TTM earnings | -150.56 |